Health for all and the problem of patents on medicines

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.

This work highlights the eternal conflict between health for all and the imperative of profitability of intellectual property linked to patents on medicines in the pharmaceutical industry. Health for all is difficult to reconcile with the need for patent profitability. Obtaining a patent for a drug is a long and costly procedure for laboratories. Obtaining it generally rhymes with an obligation of profitability. The expiration of the patent on the drug generates strategies on the part of pharmaceutical companies that are not in the service of health. Does health have a price?